Journal of Thrombosis and Thrombolysis

, Volume 36, Issue 4, pp 469–474 | Cite as

Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention

  • Alon EisenEmail author
  • Tamir Bental
  • Abid Assali
  • Ran Kornowski
  • Eli I. Lev


Mean platelet volume (MPV) is a value that is available from standard blood count. Increased MPV is associated with increased platelet reactivity and it has been correlated with adverse cardiac outcomes in patients with acute coronary syndromes (ACS). However, there is limited information about the prognostic value of baseline MPV in a large heterogenous patient population which undergoes percutaneous coronary intervention (PCI). To examine whether baseline MPV is predictive of clinical outcomes in patients who undergo PCI. Included were consecutive patients who underwent PCI during 2004–2010 (n = 7,585, mean age 67.7 ± 12.1 years, 76.0 % males) with a median follow-up period of 4 years. Baseline MPV before angiography and long-term clinical outcomes were assessed. The mean MPV was higher in women as compared to men (8.6 ± 1.2 vs. 8.5 ± 1.1 fL, p = 0.02), in diabetic versus non-diabetic patients (8.6 ± 1.2 vs. 8.4 ± 1.1 fL, p < 0.001) and in patients who were admitted with ACS (n = 4,961) compared to patients who underwent an elective PCI (8.6 ± 1.1 vs. 8.5 ± 1.1 fL, p = 0.001). On multivariate analysis, MPV was associated with mortality (HR 1.18, 95 % CI 1.12–1.23, p < 0.001) and with a composite end-point of death, MI and target vessel revascularization (HR 1.09, 95 % CI 1.04–1.13, p < 0.001). Baseline MPV was associated with mortality in patients undergoing an elective PCI as well as in urgent PCI (HR 1.30, 95 % CI 1.20–1.40, p < 0.001 and HR 1.13, 95 % CI 1.07–1.20, p < 0.001, respectively). In patients undergoing either an elective or urgent PCI, an elevated MPV is a significant predictor of cardiovascular adverse events including death.


Mean platelet volume Percutaneous coronary intervention Acute coronary syndrome 


  1. 1.
    Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescot G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, Van Werkum JW, Paganelli F, Price MJ, Waksman R, Gurbel PA (2010) Consensus and future directions on the definition of high on treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56(12):919–933PubMedCrossRefGoogle Scholar
  2. 2.
    Davi G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482–2494PubMedCrossRefGoogle Scholar
  3. 3.
    Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB (2004) Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103:2096–2104PubMedCrossRefGoogle Scholar
  4. 4.
    Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378–3384PubMedCrossRefGoogle Scholar
  5. 5.
    Kamath S, Blann AD, Lip GY (2001) Platelet activation: assessment and quantification. Eur Heart J 22:1561–1571PubMedCrossRefGoogle Scholar
  6. 6.
    Burr ML, Holliday RM, Fehily AM, Whitehead PJ (1992) Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J 13:166–170PubMedGoogle Scholar
  7. 7.
    Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G (2005) Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 46:284–290PubMedCrossRefGoogle Scholar
  8. 8.
    Pabon Osuna P, Nieto Ballesteros F, Morinigo Munoz JL, Sanchez Fernandez PL, Arribas Jimenez A, Diego Dominguez M, Martin Luengo C (1998) The effect of the mean platelet volume on the short-term prognosis of acute myocardial infarct. Rev Esp Cardiol 51(10):816–822PubMedCrossRefGoogle Scholar
  9. 9.
    Avramakis G, Papadimitraki E, Papakonstandinou D, Liakou K, Zidianakis M, Dermitzakis A, Mikhailidis DP, Ganotakis ES (2007) Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina. Platelets 18:16–23PubMedCrossRefGoogle Scholar
  10. 10.
    Van Der Lelie J, Brakenhoff JA (1983) Mean platelet volume in myocardial infarction. Br Med J (Clin Res Ed) 287:1471CrossRefGoogle Scholar
  11. 11.
    Martin JF, Bath PM, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409–1411PubMedCrossRefGoogle Scholar
  12. 12.
    Fitzgerald DJ, Roy L, Catella F, FitzGerald GA (1986) Platelet activation in unstable coronary disease. N Engl J Med 315:983–989PubMedCrossRefGoogle Scholar
  13. 13.
    Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G (2004) Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15:475–478PubMedCrossRefGoogle Scholar
  14. 14.
    Coban E, Ozdogan M, Yazicioglu G, Akcit F (2005) The mean platelet volume in patients with obesity. Int J Clin Pract 59:981–982PubMedCrossRefGoogle Scholar
  15. 15.
    Kario K, Matsuo T, Nakao K (1992) Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 14:281–287PubMedCrossRefGoogle Scholar
  16. 16.
    Vizioli L, Muscari S, Muscari A (2009) The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 63:1509–1515PubMedCrossRefGoogle Scholar
  17. 17.
    Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8:148–156PubMedCrossRefGoogle Scholar
  18. 18.
    Yang A, Pizzulli L, Luderitz B (2006) Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 117:371–377PubMedCrossRefGoogle Scholar
  19. 19.
    Mathur A, Robinson MS, Cotton J, Martin JF, Erusalimsky JD (2001) Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost 85:989–994PubMedGoogle Scholar
  20. 20.
    Pizzulli L, Yang A, Martin JF, Luderitz B (1998) Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 19(1):80–84PubMedCrossRefGoogle Scholar
  21. 21.
    Giles H, Smith RE, Martin JF (1994) Platelet glycoprotein IIb–IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 24:69–72PubMedCrossRefGoogle Scholar
  22. 22.
    Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D (1985) Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med 105:271–276PubMedGoogle Scholar
  23. 23.
    Kamath S, Blann AD, Lip GY (2002) Platelet activation: assessment and quantification. Eur Heart J 22:1561–1571CrossRefGoogle Scholar
  24. 24.
    Martin JF, Trowbridge EA, Salmon G, Plumb J (1983) The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460PubMedCrossRefGoogle Scholar
  25. 25.
    Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS (1992) The significance of platelets with increased RNA content (reticulated platelets): a measure of the rate of thrombopoiesis. Am J Clin Pathol 98:637–646PubMedGoogle Scholar
  26. 26.
    Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI (2008) Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 52:743–749PubMedCrossRefGoogle Scholar
  27. 27.
    Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D (2007) Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49:2312–2317PubMedCrossRefGoogle Scholar
  28. 28.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA (2007) Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49:1505–1516PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Alon Eisen
    • 1
    • 2
    Email author
  • Tamir Bental
    • 1
    • 2
  • Abid Assali
    • 1
    • 2
  • Ran Kornowski
    • 1
    • 2
  • Eli I. Lev
    • 1
    • 2
  1. 1.Cardiology DepartmentRabin Medical CenterPetah TikvaIsrael
  2. 2.Sackler Faculty of Medicine, Tel Aviv UniversityTel AvivIsrael

Personalised recommendations